Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP668102.RAXHlokjhRM94vPL3S-RvMTKtIK_kTDnNYsc_F_Zctk2M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP668102.RAXHlokjhRM94vPL3S-RvMTKtIK_kTDnNYsc_F_Zctk2M130_assertion type Assertion NP668102.RAXHlokjhRM94vPL3S-RvMTKtIK_kTDnNYsc_F_Zctk2M130_head.
- NP668102.RAXHlokjhRM94vPL3S-RvMTKtIK_kTDnNYsc_F_Zctk2M130_assertion description "[Analyses obtained with 164 lymph nodes from patients free of cancer and 15 nodes harboring metastases established a threshold for metastatic disease of approximately 200 GCC mRNA copies/mug total RNA, with a sensitivity of 93% and specificity of 97%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668102.RAXHlokjhRM94vPL3S-RvMTKtIK_kTDnNYsc_F_Zctk2M130_provenance.
- NP668102.RAXHlokjhRM94vPL3S-RvMTKtIK_kTDnNYsc_F_Zctk2M130_assertion evidence source_evidence_literature NP668102.RAXHlokjhRM94vPL3S-RvMTKtIK_kTDnNYsc_F_Zctk2M130_provenance.
- NP668102.RAXHlokjhRM94vPL3S-RvMTKtIK_kTDnNYsc_F_Zctk2M130_assertion SIO_000772 16899600 NP668102.RAXHlokjhRM94vPL3S-RvMTKtIK_kTDnNYsc_F_Zctk2M130_provenance.
- NP668102.RAXHlokjhRM94vPL3S-RvMTKtIK_kTDnNYsc_F_Zctk2M130_assertion wasDerivedFrom befree-20140225 NP668102.RAXHlokjhRM94vPL3S-RvMTKtIK_kTDnNYsc_F_Zctk2M130_provenance.
- NP668102.RAXHlokjhRM94vPL3S-RvMTKtIK_kTDnNYsc_F_Zctk2M130_assertion wasGeneratedBy ECO_0000203 NP668102.RAXHlokjhRM94vPL3S-RvMTKtIK_kTDnNYsc_F_Zctk2M130_provenance.